Sort by
Keyphrases
Receptor-mediated
100%
Doxorubicin
100%
Adenosine A3 Receptor
100%
Cardioprotection
100%
Mitochondrial Damage
100%
Cl-IB-MECA
83%
Echocardiography
33%
Ca2+ Overload
33%
Sarcoplasmic Reticulum Calcium
33%
Sarcoplasmic Reticulum
33%
Ca2+
16%
Newborn Rats
16%
Storage Capacity
16%
Adenosine
16%
Selective Agonist
16%
Mitochondria
16%
Indo-1
16%
Caffeine
16%
Left Ventricular Dysfunction
16%
Chloro
16%
Rat Cardiomyocytes
16%
Cardiotoxicity
16%
Ca2+ Homeostasis
16%
Calcium Level
16%
Therapeutic Efficiency
16%
Left Ventricular Wall
16%
Wall Thinning
16%
Left Ventricular Function
16%
Fractional Shortening
16%
Calcium Release
16%
Cardiac Depression
16%
Doxorubicin-induced Cardiotoxicity
16%
Ca2+ Uptake
16%
Calcium Storage
16%
Cultured Cardiomyocytes
16%
Calcium Uptake
16%
Ca2+ Accumulation
16%
A3 Adenosine Receptor
16%
Adenosine A3 Receptor Agonist
16%
Rhod-2
16%
Invasive Pressure
16%
Injection Period
16%
Ca2+ Content
16%
Doxorubicin Treatments
16%
Doxorubicin Toxicity
16%
Medicine and Dentistry
Heart Protection
100%
Adenosine A3 Receptor
100%
Doxorubicin
100%
Calcium Ion
77%
Namodenoson
55%
Sarcoplasmic reticulum
44%
Calcium Transport
22%
Isotopes of Calcium
22%
Echocardiography
22%
Cardiac Muscle Cell
22%
Cardiotoxicity
22%
Malignant Neoplasm
11%
Homeostasis
11%
Neonatal Infant
11%
Adenosine
11%
Mitochondrion
11%
Sodium Chloride
11%
Heart Left Ventricle Failure
11%
Cytosol
11%
Heart Left Ventricle Function
11%
Indo 1
11%
Adenosine A3 Receptor Agonist
11%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Adenosine A3 Receptor
100%
Calcium Ion
77%
Namodenoson
55%
Cardiotoxicity
22%
Malignant Neoplasm
11%
Adenosine A3 Receptor Agonist
11%
Indo 1
11%
Heart Left Ventricle Failure
11%
Sodium Chloride
11%
Adenosine
11%